🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will test a drug called enfortumab vedotin in participants with ...
Status
Terminated
Location
Banner MD Anderson Cancer Center
Start Date
2021-12-07
Trial ID
NCT05014139
Treatments Being Tested
The primary purpose of this study is to determine the antitumor activity of...
Status
Active Not Recruiting
Location
Arizona Oncology
Start Date
2020-03-10
Trial ID
NCT04225117
Treatments Being Tested
People with a type of bladder cancer called muscle-invasive bladder cancer ...
Status
Recruiting
Location
Arkansas Urology Associates
Start Date
2026-03-12
Trial ID
NCT07475806
Treatments Being Tested
A study examining the safety of AGS-22M6E or ASG-22CE administered as monot...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2011-07-11
Trial ID
NCT01409135
The primary purpose of this expanded access program is to evaluate safety a...
Status
Approved For Marketing
Location
UCLA Hematology Oncology
Start Date
TBD
Trial ID
NCT04136808
Treatments Being Tested
The purpose of this study was to compare the overall survival (OS) of parti...
Status
Completed
Location
UCI Chao Family Comprehensive Cancer Center
Start Date
2018-06-27
Trial ID
NCT03474107
Treatments Being Tested
The purpose of this study was to determine the antitumor activity of enfort...
Status
Completed
Location
Site CN86001
Start Date
2021-07-22
Trial ID
NCT04995419
Treatments Being Tested
This is a study that will test how an experimental drug (enfortumab vedotin...
Status
Completed
Location
Alaska Urological Institute
Start Date
2017-10-08
Trial ID
NCT03219333
Treatments Being Tested
This phase II trial compares therapeutic plasma exchange followed by enfort...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-08-01
Trial ID
NCT07087860
This study is a substudy being conducted under one pembrolizumab umbrella m...
Status
Active Not Recruiting
Location
Moores Cancer Center ( Site 3028)
Start Date
2023-06-23
Trial ID
NCT05845814
Treatments Being Tested